Advertisement

Topics

Alexo Therapeutics Presents Preliminary Results from ALX148 Phase 1 Clinical Trial in Patients with Advanced Solid Tumors and Lymphoma

06:00 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
-Data presented at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC), in National Harbor, Maryland- Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies that block the C...

Other Sources for this Article

MacDougall Biomedical Communications
Karen Sharma or Shai Biran, Ph.D., 781-235-3060
alexo@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "Alexo Therapeutics Presents Preliminary Results from ALX148 Phase 1 Clinical Trial in Patients with Advanced Solid Tumors and Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...